Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Financing Activities (2016 - 2025)

Haemonetics has reported Cash from Financing Activities over the past 17 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $2.0 million for Q4 2025, up 47.32% from a year ago — trailing twelve months through Dec 2025 was -$228.4 million (down 216.08% YoY), and the annual figure for FY2025 was $108.8 million, up 185.18%.
  • Cash from Financing Activities for Q4 2025 was $2.0 million at Haemonetics, up from -$76.6 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for HAE hit a ceiling of $432.8 million in Q2 2021 and a floor of -$151.4 million in Q1 2025.
  • Median Cash from Financing Activities over the past 5 years was -$2.9 million (2021), compared with a mean of $19.3 million.
  • Peak annual rise in Cash from Financing Activities hit 55901.34% in 2024, while the deepest fall reached 3861.45% in 2024.
  • Haemonetics' Cash from Financing Activities stood at -$3.3 million in 2021, then crashed by 1398.64% to -$49.7 million in 2022, then soared by 320.27% to $109.4 million in 2023, then tumbled by 98.74% to $1.4 million in 2024, then surged by 47.32% to $2.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were $2.0 million (Q4 2025), -$76.6 million (Q3 2025), and -$2.4 million (Q2 2025) per Business Quant data.